Harms and benefits of sodium-glucose co-transporter 2 inhibitors

Sodium-glucose co-transporter 2 inhibitors are oral glucose-lowering drugs that increase the urinary excretion of glucose. In patients with type 2 diabetes and cardiovascular disease they reduce all-cause mortality, cardiac mortality, rates of hospitalisation for heart failure and the progression of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chesterman, Thomas, Thynne, Tilenka RJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572185/
https://www.ncbi.nlm.nih.gov/pubmed/33093744
http://dx.doi.org/10.18773/austprescr.2020.049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572185/
https://www.ncbi.nlm.nih.gov/pubmed/33093744
http://dx.doi.org/10.18773/austprescr.2020.049

Ejemplares similares